Acrivon Therapeutics
ACRV
#9604
Rank
$42.32 M
Marketcap
$1.35
Share price
-2.88%
Change (1 day)
-77.16%
Change (1 year)

Earnings for Acrivon Therapeutics (ACRV)

Earnings in 2024 (TTM): -$89.2 Million USD

According to Acrivon Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -$67.11 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acrivon Therapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 -$89.2 Million32.93%
2023 -$67.11 Million105.48%
2022 -$32.66 Million